Diagnosis and treatment of prolactinomas: the patient's perspective anno 2025

Abstract

Prolactinoma manifestations have long been regarded as mild, yet recent evidence

suggests the consequences are more impactful and treatment is less optimal than

previously thought. The aim of this thesis was to present novel insights into outcome

evaluations, diagnosis, and treatment of prolactinomas. By using patient-reported outcomes alongside the traditional biochemical, radiologic, and clinician-reported outcomes, this thesis aimed to gain a deeper understanding of the patients’ disease burden and identify areas of care that require improvement.